🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Primary Biliary Cholangitis

A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis NCT05751967Phase 37 sites📍 Lanzhou📍 Guangzhou📍 Nanjing Xijing Hospital of Digestive Diseases · Tests: Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With Ursodeoxycholic Acid Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy NCT07556913n/a1 site📍 Wilmington Ipsen · Tests: Elafibranor Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients NCT04753996n/a1 site📍 Rochester Mayo Clinic Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) NCT06365424Phase 2, Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach NCT04685200n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis NCT06051617Phase 3217 sites📍 Birmingham📍 Phoenix📍 Lancaster Gilead Sciences · Tests: Seladelpar, Placebo Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin NCT02137668Phase 11 site📍 Sacramento Sacramento Pediatric Gastroenterology · Tests: Oral Vancomycin A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC NCT06699121Phase 27 sites📍 Sacramento📍 Aurora📍 Iowa City LISCure Biosciences · Tests: LB-P8 low-dose, LB-P8 high-dose, Placebo A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis NCT07387549Phase 3231 sites📍 Chandler📍 Phoenix📍 Coronado Ipsen · Tests: Elafibranor, Placebo A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) NCT07229911Phase 11 site📍 Salt Lake City Takeda · Tests: TAK-781, Placebo Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy NCT07424677Phase 31 site📍 Lakewood Rch Zydus Therapeutics Inc. · Tests: Saroglitazar Magnesium 1 mg, Placebo Biodegradable Stents in Primary Sclerosing Cholangitis NCT07607353NA1 site📍 London King's College Hospital NHS Trust · Tests: archimedes stent Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. NCT05295680Phase 22 sites📍 Redwood City📍 Stanford Aparna Goel · Tests: Hymecromone Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site📍 Mexico City Coordinación de Investigación en Salud, Mexico · Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experienced… Detection Program for Patients With Primary Biliary Cholangitis Lost in the System NCT05919433n/a1 site📍 Terrassa Hospital Mutua de Terrassa Biochemical Response and Clinical Outcomes in Patients With PBC NCT07449793n/a1 site📍 Shanghai RenJi Hospital · Tests: Only observation Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy NCT07296458Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA (Ursodeoxycholic acid) Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study NCT05912387EARLY Phase 11 site📍 Stanford Stanford University · Tests: Rosuvastatin Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy NCT06443606Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Bezafibrate 400 mg in addition to UDCA therapy, Bezafibrate 200 mg in addition to UDCA therapy, Placebo in addition to … Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) NCT07205874n/a1 site📍 Madrid Hospital Universitario La Paz Primary Sclerosing Cholangitis in Children NCT04181138n/a12 sites📍 Los Angeles📍 Aurora📍 Atlanta Arbor Research Collaborative for Health LEOPARD Prospective Validation Cohort 1 NCT06723275n/a8 sites📍 Ghent📍 Clichy📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Standardized assessments, guided tumor biopsy and biobanking, Standardized assessments and biobanking MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease NCT03178630n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Swiss Primary Biliary Cholangitis Cohort Study NCT03146910n/a13 sites📍 Lugano📍 Basel📍 Bern Fondazione Epatocentro Ticino Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis NCT07341282Phase 21 site📍 Hamilton McMaster University · Tests: Placebo (blinded), Vancomycin (blinded), Vancomycin (open-label extension) Biobank for Cholestatic Liver Diseases. NCT03445585n/a1 site📍 Rochester Mayo Clinic RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis NCT07161245NA1 site📍 Barcelona Hospital Clinic of Barcelona · Tests: Multimodal prehabilitation, standard of care PBC Long-term Outcomes Study NCT07149675n/a1 site📍 Beijing Beijing Friendship Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy